Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Multiple Sclerosis and Commensal Gut Flora].
Administrative databases for observational studies in multiple sclerosis: power or peril?
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
[Cytology of cerebrospinal fluid : Standards, importance and modern methods].
IL-3 promotes the development of experimental autoimmune encephalitis.
Diffusion Tensor Imaging Tractography in Pure Neuritic Leprosy: First Experience Report and Review of the Literature.
miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.
Central pontine myelinolysis caused by hypernatremia.
Juvenile striatal white matter is resistant to ischemia-induced damage.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
What is the future of proof of concept studies in multiple sclerosis?
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
Endocannabionoid System in Neurological Disorders.
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
How have research questions and methods used in clinical trials published in Clinical Rehabilitation changed over the last 30 years?
Aldynoglia cells and modulation of RhoGTPase activity as useful tools for spinal cord injury repair.
Therapeutic antibodies for spinal cord injury.
[Improving the sexual quality of life of people with multiple sclerosis].
Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro.
Resistance of subventricular neural stem cells to chronic hypoxemia despite structural disorganization of the germinal center and impairment of neuronal and oligodendrocyte survival.
Pages
« first
‹ previous
…
780
781
782
783
784
785
786
787
788
…
next ›
last »